LCBiot-DLDLEMLAPYIPMDDDFQL-OH

Ref. 3D-PP48513

Produktinformation

• Name: LCBiot-DLDLEMLAPYIPMDDDFQL-OH

Beschreibung

Peptide LCBiot-DLDLEMLAPYIPMDDDFQL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-DLDLEMLAPYIPMDDDFQL-OH include the following: Effects of polynitrogen compounds on the activity of recombinant human HIF-1alpha prolyl hydroxylase 3 in E. coli Z Geng, J Zhu, J Cao, J Geng, X Song, Z Zhang - Journal of Inorganic , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0162013410002758 Assays to Study Hypoxia-Inducible Factor Prolyl Hydroxylase Domain 2 (PHD2), a Key Human Oxygen Sensing Protein YY Chan, NM Mbenza, MC Chan - Oxygen Sensing: Methods , 2023 - Springerhttps://link.springer.com/protocol/10.1007/978-1-0716-3080-8_12 Affinity-based fluorescence polarization assay for high-throughput screening of prolyl hydroxylase 2 inhibitors Y Lei, T Hu, X Wu, Y Wu , Q Bao , L Zhang - ACS medicinal , 2015 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsmedchemlett.5b00394 Discovery of clinical candidate (5-(3-(4-chlorophenoxy) prop-1-yn-1-yl)-3-hydroxypicolinoyl) glycine, an orally bioavailable prolyl hydroxylase inhibitor for the X Zhang, Y Lei, T Hu, Y Wu , Z Li , Z Jiang - Journal of Medicinal , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.0c01161 Kinetic analysis of HIF prolyl hydroxylases P Koivunen , J Myllyharju - Hypoxia: Methods and Protocols, 2018 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-7665-2_2 Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2 NL Richardson, LJ O'Malley, D Weissberger - Bioorganic & Medicinal , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089621001231 Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain MC Chan , O Atasoylu , E Hodson, A Tumber - PLoS , 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132004 Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor M Hirsila, P Koivunen , V Gunzler, KI Kivirikko - Journal of Biological , 2003 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)84109-X/abstract Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2 KS Hewitson, CJ Schofield, PJ Ratcliffe - Methods in enzymology, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0076687907350027 Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways K Ullah , AH Rosendahl, V Izzi , U Bergmann - Scientific Reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-17376-0 Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy JH Dao, RJM Kurzeja, JM Morachis , H Veith - Analytical , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269708006805 A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity F Oehme, W Jonghaus, L Narouz-Ott, J Huetter - Analytical , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003269704003240 Kinetic rationale for selectivity toward N-and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl E Flashman, EAL Bagg , R Chowdhury - Journal of Biological , 2008 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)69690-9/abstract The long form of pVHL is artifactually modified by serine protease inhibitor AEBSF D Tarade , S He, J St-Germain, A Petroff - Protein , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pro.3898

• Marke: Biosynth